Introducing Dx:Revenue - Precision Medicine Intelligence for Business Development Teams

LEARN MORE
Posts Currently viewing the category: "Press Release"
Pharma Services Partnership Software

Announcing Dx:Revenue

by

Amplion’s Machine Learning Platform Accelerates Precision Medicine Collaboration Dx:Revenue™ solution rapidly identifies and qualifies drug and test developer partnership opportunities Effective partnerships between pharmaceutical companies, biotechs, academia, diagnostic companies, CROs and other players along the drug development continuum are vital to achieving the realization of precision medicine For diagnostic and test providers in…(Read More)

Biomarker Intelligence company to aggressively accelerate sales, marketing and execution of product roadmap Amplion, an Oregon-based Biomarker Intelligence company, announced the successful close of its Series A financing led by Greycroft with participation from existing investors, including Revolution’s Rise of the Rest Seed Fund and Imagen Capital Partners. The funds will help the…(Read More)